Basit öğe kaydını göster

dc.contributor.authorHAWKINS, T
dc.contributor.authorADALET, IŞIK
dc.contributor.authorWILKINSON, R
dc.contributor.authorCLARK, F
dc.date.accessioned2021-03-06T09:58:30Z
dc.date.available2021-03-06T09:58:30Z
dc.date.issued1994
dc.identifier.citationADALET I., HAWKINS T., CLARK F., WILKINSON R., "THALLIUM-TECHNETIUM-SUBTRACTION SCINTIGRAPHY IN SECONDARY HYPERPARATHYROIDISM", EUROPEAN JOURNAL OF NUCLEAR MEDICINE, cilt.21, ss.509-513, 1994
dc.identifier.issn0340-6997
dc.identifier.othervv_1032021
dc.identifier.otherav_e8090245-4743-4179-abec-398c89f5bda1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/152553
dc.identifier.urihttps://doi.org/10.1007/bf00173037
dc.description.abstractBetween 1983 and 1992 thallium-technetium subtraction scintigraphy (TTS) was performed on 74 patients with clinical and biochemical evidence of hyperparathyroidism. Twenty-five of the 53 investigations since 1988 were conducted on patients with renal failure with a suspicion of secondary hyperparathyroidism. In a retrospective study we have evaluated radioisotope scintigraphy for patients with adenoma and for renal failure patients with possible parathyroid hyperplasia. Thirty of 74 patients underwent neck exploration. Scintigraphy detected 17 of 24 parathyroid adenomas (sensitivity 71%). In contrast, in six renal patients who came to operation, scintigraphy localised only 5 of 20 hyperplastic parathyroid glands (sensitivity 25%) and in one renal patient we localised a parathyroid adenoma. A review of the literature shows low detection rates for hyperplasia by TTS to be a common observation. Based on these findings a rational approach is offered for parathyroid localisation in renal patients prior to neck exploration.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectNükleer Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleTHALLIUM-TECHNETIUM-SUBTRACTION SCINTIGRAPHY IN SECONDARY HYPERPARATHYROIDISM
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF NUCLEAR MEDICINE
dc.contributor.department, ,
dc.identifier.volume21
dc.identifier.issue6
dc.identifier.startpage509
dc.identifier.endpage513
dc.contributor.firstauthorID728740


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster